Cargando…
Seroconversion of severe acute respiratory syndrome coronavirus 2–infected patients on immunosuppression: A retrospective analysis
Autores principales: | Smith, Jeffrey S., Said, Jordan T., Elman, Scott A., Smith, Claire E.P., Merola, Joseph F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860940/ https://www.ncbi.nlm.nih.gov/pubmed/33549649 http://dx.doi.org/10.1016/j.jaad.2021.01.100 |
Ejemplares similares
-
Exposure and seroconversion to severe acute respiratory syndrome coronavirus 2 among obstetrical healthcare providers following a contained outbreak
por: Kiefer, Miranda K., et al.
Publicado: (2020) -
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Staines, Henry M., et al.
Publicado: (2021) -
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants
por: Alfano, Gaetano, et al.
Publicado: (2021) -
Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency
por: Squire, Jacqueline, et al.
Publicado: (2021) -
Glomerular basement membrane nephritis: crescentic renal inflammation and immunosuppressive intervention in the time of the severe acute respiratory syndrome coronavirus 2 pandemic
por: Brix, Silke R., et al.
Publicado: (2021)